Defects in bile acid biosynthesis--diagnosis and treatment.
暂无分享,去创建一个
[1] Jeffrey B. Cheng,et al. Molecular Genetics of 3β-Hydroxy-Δ5-C27-Steroid Oxidoreductase Deficiency in 16 Patients with Loss of Bile Acid Synthesis and Liver Disease , 2003 .
[2] F. Suchy,et al. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. , 1988, The Journal of clinical investigation.
[3] B. Strandvik,et al. DEFECTIVE BILE ACID AMIDATION: PREDICTED FEATURES OF A NEW INBORN ERROR OF METABOLISM , 1988, The Lancet.
[4] Celeste Eng,et al. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. , 2002, The Journal of clinical investigation.
[5] A. Moser,et al. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. , 2003, Gastroenterology.
[6] I. Björkhem,et al. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. , 1980, The Journal of clinical investigation.
[7] N. Le,et al. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis. , 1989, Journal of lipid research.
[8] M. Afschrift,et al. Lipid-lowering effects of procetofene. , 1977 .
[9] L. V. Bogaert,et al. Une forme cérébrale de la cholestérinose généralisée : type particulier de lipidose à cholestérine , 1937 .
[10] J. Heubi,et al. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (Δ4‐3‐oxosteroid 5β‐reductase deficiency) , 1993 .
[11] K. Setchell,et al. Oral bile acid treatment and the patient with zellweger syndrome , 1992, Hepatology.
[12] P. Clayton,et al. 3β-hydroxy-Δ5-C27-steroid dehydrogenase deficiency; effect of chenodeoxycholic acid therapy on liver histology , 1992, Journal of Inherited Metabolic Disease.
[13] G. Tint,et al. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis. , 1979, The Journal of clinical investigation.
[14] P. Meier,et al. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. , 1997, European journal of biochemistry.
[15] R. Wanders,et al. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy. , 1986, The American journal of pathology.
[16] A. Hofmann,et al. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis , 2005, Digestive Diseases and Sciences.
[17] J. Sjövall,et al. Mass spectrometry of bile acids. , 1985, Methods in enzymology.
[18] K. Bove,et al. Bile Acid Synthetic Defects and Liver Disease , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[19] G. Salen,et al. Bile acid biosynthesis , 1974, The American Journal of Digestive Diseases.
[20] D. Russell,et al. Bile acid biosynthesis. , 1992, Biochemistry.
[21] H. Moser,et al. Infantile Refsum's disease: Biochemical findings suggesting multiple peroxisomal dysfunction , 1986, Journal of Inherited Metabolic Disease.
[22] K. S. Kim,et al. Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families. , 1997, Journal of lipid research.
[23] P. Clayton,et al. Treatment of chronic liver disease caused by 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency with chenodeoxycholic acid. , 1990, Archives of disease in childhood.
[24] R. Wevers,et al. Mutations in the sterol 27-hydoxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis , 2002, Journal of Inherited Metabolic Disease.
[25] A. Larghi,et al. Clinical Pharmacokinetics of Therapeutic Bile Acids , 1996, Clinical pharmacokinetics.
[26] U. Francke,et al. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.
[27] G. Tint,et al. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. , 1974, The Journal of clinical investigation.
[28] J. C. van der Molen,et al. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[29] P. Clayton,et al. Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. , 1987, The Journal of clinical investigation.
[30] J. Sjövall,et al. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. , 1977, Journal of lipid research.
[31] W. Lim,et al. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT , 2003, Nature Genetics.
[32] P. Scambler,et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. , 2003, Gut.
[33] A. Hofmann,et al. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis part II , 1982, Digestive Diseases and Sciences.
[34] P. Clayton,et al. Familial giant cell hepatitis associated with synthesis of 3β,7α-dihydroxy- and 3β,7α,12α-trihydroxy-5-cholenoic acid , 1987 .
[35] R. Lathe,et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. , 1998, The Journal of clinical investigation.
[36] R. Preisig,et al. Monohydroxy bile salt sulfates: Tauro-3β-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats , 1983 .
[37] S. Grundy,et al. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. , 1973, The Journal of clinical investigation.